Elenbecestat : Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy

Ponatinib : Targeting plasma cells with daratumumab aids in the treatment of post-transplant autoimmune-like hepatitis

Nirmatrelvir : Impact of oral early antiviral therapies for mild-moderate COVID-19 in the outpatient’s setting during Omicron era: a pharmacoeconomic analysis

EGFR inhibitor: Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer

Borussertib : Si-Ni Decoction as a Potential Treatment for Ulcerative Colitis: Modulation of Gut Microbiota and AKT1 Inhibition Through Network Pharmacology and in vivo Validation